In vitro time-kill activities of ciprofloxacin alone and in combination with the iron chelator deferasirox against Vibrio vulnificus
- 2 February 2010
- journal article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 29 (4), 407-410
- https://doi.org/10.1007/s10096-010-0875-5
Abstract
Iron plays a major role in the growth and virulence of ferrophilic organisms like Vibrio vulnificus. People who reside in the coastal areas with raw fish eating habits have a high risk of Vibrio infection and aggressive therapy can only reduce their mortality. We investigated the in vitro efficacy of ciprofloxacin, a bactericidal drug used in V. vulnificus patients, and the orally active iron chelator deferasirox against V. vulnificus infection. We performed in vitro time-kill studies on two ATCC strains and one clinical isolate of V. vulnificus collected from a patient admitted to Chosun University Hospital with either ciprofloxacin or iron chelator deferasirox alone and the two drugs in combination. The combination of an iron chelator plus an antibiotic creates a novel form of synergism at 24 h. The antimicrobial effect of deferasirox may be ascribed to its ability to deplete iron that would otherwise be used for bacterial growth. Combination therapy with ciprofloxacin plus deferasirox has potential clinical application by lowering the iron availability against a ferrophilic organism like V. vulnificus infections.Keywords
This publication has 16 references indexed in Scilit:
- Comparison of the effects of deferasirox, deferiprone, and deferoxamine on the growth and virulence of Vibrio vulnificusTransfusion, 2009
- Deferasirox plus ciprofloxacin combination therapy after rapid diagnosis of Vibrio vulnificus sepsis using real-time polymerase chain reactionJournal of Infection, 2008
- In Vitro Activity of Tigecycline against Multidrug-Resistant Acinetobacter baumannii and Selection of Tigecycline-Amikacin SynergyAntimicrobial Agents and Chemotherapy, 2008
- Time Kill Studies of Antibiotics against a Nalidixic Acid Resistant Salmonella enterica serotype TyphiInfection and Chemotherapy, 2008
- A Widespread Deferoxamine‐Mediated Iron‐Uptake System inVibrio vulnificusThe Journal of Infectious Diseases, 2007
- Ferrophilic Characteristics ofVibrio vulnificusand Potential Usefulness of Iron Chelation TherapyThe Journal of Infectious Diseases, 2007
- In Vitro Efficacy of the Combination of Ciprofloxacin and Cefotaxime against Vibrio vulnificusAntimicrobial Agents and Chemotherapy, 2005
- Iron: Mammalian defense systems, mechanisms of disease, and chelation therapy approachesBlood Reviews, 1995
- Synergy between the iron chelator deferoxamine and the antimicrobial agents gentamicin, chloramphenicol, cefalothin, cefotiam and cefsulodinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983
- Bacterial Assimilation of ironCRC Critical Reviews in Microbiology, 1973